Last update 23 Jan 2025

Penn Pharmaceuticals Group Ltd.

Private Company|
2004|
United Kingdom

Overview

Tags

Congenital Disorders
Immune System Diseases
Endocrinology and Metabolic Disease
Molecular glue

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Hemic and Lymphatic Diseases1
Infectious Diseases1
Immune System Diseases1
Neoplasms1
Top 5 Drug TypeCount
Molecular glue1
Top 5 TargetCount
CK1α x CRBN x IKZF1 x IKZF31

Related

1
Drugs associated with Penn Pharmaceuticals Group Ltd.
Lenalidomide
Target
CK1α x CRBN x IKZF1 x IKZF3
Mechanism
CK1α inhibitors [+3]
Active Org.
Incyte Corp.Incyte Corp. [+30]
Originator Org.
Celgene Corp.Celgene Corp.
Active Indication
Marginal Zone B-Cell Lymphoma [+63]
Inactive Indication
Aase Smith Syndrome 2 [+110]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date27 Dec 2005
1
Clinical Trials associated with Penn Pharmaceuticals Group Ltd.
CTR20132976
/ Active, not recruitingPhase 3
评价来那度胺联合低剂量地塞米松一线治疗多发性骨髓瘤的疗效及安全性的随机开放3个治疗组的Ⅲ期研究
[Translation] A randomized, open-label, phase III study evaluating the efficacy and safety of lenalidomide combined with low-dose dexamethasone as first-line treatment for multiple myeloma
100 Clinical Results associated with Penn Pharmaceuticals Group Ltd.
Login to view more data
0 Patents (Medical) associated with Penn Pharmaceuticals Group Ltd.
Login to view more data
100 Deals associated with Penn Pharmaceuticals Group Ltd.
Login to view more data
100 Translational Medicine associated with Penn Pharmaceuticals Group Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 01 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Lenalidomide
 ( CK1α x CRBN x IKZF1 x IKZF3 )		Multiple Myeloma
More
Phase 3
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free